|
1. Biologie
|
|
|
|
2. Etiologie
|
|
|
|
4.12 Biopsies liquides
|
|
|
Artificial Intelligence to Boost Liquid Biopsies [The Scientist]
|
|
|
|
|
|
Because
of this limitation, only targeted assays of known cancer mutations have
so far been possible. But many cancers lack a simple set of known
mutations that can identify a tumor and, subsequently, determine the
best treatment option. That’s where machine-learning comes in.
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
|
5.12.2 Immunothérapies - CAR-T, thérapies cellulaires
|
|
|
AbbVie powers CAR-macrophage startup Carisma to $53M A round [FierceBiotech]
|
|
|
|
|
|
Combining
CARs with macrophages, not T cells, is intended to create therapies
better equipped to take out solid tumors than CAR-Ts. Modified T cells
struggle to reach solid tumors and survive in the immunosuppressive
microenvironment that surrounds them, leading to weaker efficacy than is
seen in blood cancers.
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA,...)
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
6.6 Publications
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
The Topol Review [NHS]
|
|
|
|
|
|
This
will enable NHS staff to make the most of game-changing technologies
such as genomics, digital medicine, artificial intelligence and robotics
to improve services and help ensure a sustainable NHS.
|
|
|
|
|
|
|
6.9 Controverses
|
|
|